What is NDC 59651-621?

59651-621 is the product NDC for Mycophenolic Acid, Mycophenolate sodium 180 mg/1 tablet, delayed release, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Mycophenolic Acid?

34 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Mycophenolic Acid NDC 59651-621 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-621Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0621Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-621-08	5965106210859651062108	120 TABLET, DELAYED RELEASE in 1 BOTTLE (59651-621-08)Marketed from Feb 27, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Mycophenolic Acid
Generic name (nonproprietary): mycophenolic acid
Active ingredients: Mycophenolate sodium — 180 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218603
Marketing start: Feb 27, 2024
Listing expires: Dec 31, 2027
Identifiers: Product ID 59651-621_c88372f5-7138-434f-b730-5b3b6f86ec4dSPL ID c88372f5-7138-434f-b730-5b3b6f86ec4d
Pharmacologic class: Antimetabolite Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651062108 followed by a unit qualifier and the quantity

Package 59651-0621-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 59651-621

What is NDC 59651-621?: 59651-621 is the product NDC for Mycophenolic Acid, Mycophenolate sodium 180 mg/1 tablet, delayed release, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Mycophenolic Acid.
What is the active ingredient?: Mycophenolate sodium.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Mycophenolic Acid?: 34 other product NDCs are listed under this name. See all Mycophenolic Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Mycophenolic Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
mycophenolic acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Stellon Biotech Inc.	85972-161	85972-0161-12
mycophenolic acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Stellon Biotech Inc.	85972-162	85972-0162-12
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Ascend Laboratories, LLC	67877-928	67877-0928-0567877-0928-1267877-0928-38
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Ascend Laboratories, LLC	67877-929	67877-0929-0567877-0929-1267877-0929-38
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	REMEDYREPACK INC.	70518-4391	70518-4391-00
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Major Pharmaceuticals	0904-7372	00904-7372-0400904-7372-61
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Biocon Pharma Inc.	70377-126	70377-0126-11
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Biocon Pharma Inc.	70377-127	70377-0127-11
Mycophenolic Acid	Mycophenolate sodium 180 mg/1	Tablet, Delayed releaseOral	Novugen Pharma (USA) LLC.	82293-012	82293-0012-10
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Novugen Pharma (USA) LLC.	82293-013	82293-0013-10

All 35 Mycophenolic Acid NDCs

Other NDCs under ANDA 218603

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218603
Product	Strength	Form · route	Labeler	Product NDC
Mycophenolic Acid	Mycophenolate sodium 360 mg/1	Tablet, Delayed releaseOral	Aurobindo Pharma Limited	59651-622